Vivos Therapeutics, Inc. (VVOS) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$19.89M | -78.1% |
| 2024 | -$11.17M | +35.4% |
| 2023 | -$17.30M | +30.9% |
| 2022 | -$25.03M | -22.8% |
| 2021 | -$20.38M | -69.3% |
| 2020 | -$12.04M | -13.8% |
| 2019 | -$10.58M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$19.89M | -78.1% |
| 2024 | -$11.17M | +35.4% |
| 2023 | -$17.30M | +30.9% |
| 2022 | -$25.03M | -22.8% |
| 2021 | -$20.38M | -69.3% |
| 2020 | -$12.04M | -13.8% |
| 2019 | -$10.58M | — |